These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 11507649
1. Expression of arginine vasopressin and vasopressin V1a receptor mRNA in diabetic (db/db) mice. Morita M, Kita Y, Morikawa N, Iwami M, Notsu Y. Exp Clin Endocrinol Diabetes; 2001; 109(5):261-6. PubMed ID: 11507649 [Abstract] [Full Text] [Related]
2. Traumatic brain injury results in a concomitant increase in neocortical expression of vasopressin and its V1a receptor. Pascale CL, Szmydynger-Chodobska J, Sarri JE, Chodobski A. J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():161-7. PubMed ID: 17244947 [Abstract] [Full Text] [Related]
3. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice. Hiroyama M, Wang S, Aoyagi T, Oikawa R, Sanbe A, Takeo S, Tanoue A. Eur J Pharmacol; 2007 Mar 22; 559(2-3):89-97. PubMed ID: 17275806 [Abstract] [Full Text] [Related]
4. Salt-loading increases vasopressin and vasopressin 1b receptor mRNA in the hypothalamus and choroid plexus. Zemo DA, McCabe JT. Neuropeptides; 2001 Mar 22; 35(3-4):181-8. PubMed ID: 11884209 [Abstract] [Full Text] [Related]
5. Ageing and the diurnal expression of the mRNAs for vasopressin and for the V1a and V1b vasopressin receptors in the suprachiasmatic nucleus of male rats. Kalamatianos T, Kalló I, Coen CW. J Neuroendocrinol; 2004 Jun 22; 16(6):493-501. PubMed ID: 15189323 [Abstract] [Full Text] [Related]
6. Enhanced effect of neuropeptide Y on food intake caused by blockade of the V(1A) vasopressin receptor. Aoyagi T, Kusakawa S, Sanbe A, Hiroyama M, Fujiwara Y, Yamauchi J, Tanoue A. Eur J Pharmacol; 2009 Nov 10; 622(1-3):32-6. PubMed ID: 19766110 [Abstract] [Full Text] [Related]
7. Enhanced glucose tolerance in the Brattleboro rat. Nakamura K, Yamashita T, Fujiki H, Aoyagi T, Yamauchi J, Mori T, Tanoue A. Biochem Biophys Res Commun; 2011 Feb 04; 405(1):64-7. PubMed ID: 21215256 [Abstract] [Full Text] [Related]
8. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates. Louiset E, Contesse V, Groussin L, Cartier D, Duparc C, Perraudin V, Bertherat J, Lefebvre H. J Endocrinol; 2008 Jan 04; 196(1):1-9. PubMed ID: 18180312 [Abstract] [Full Text] [Related]
9. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. Jung UJ, Lee MK, Park YB, Jeon SM, Choi MS. J Pharmacol Exp Ther; 2006 Aug 04; 318(2):476-83. PubMed ID: 16644902 [Abstract] [Full Text] [Related]
10. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice. Howarth AG, Wiehler WB, Pannirselvam M, Jiang Y, Berger JP, Severson D, Anderson TJ, Triggle CR. J Pharmacol Exp Ther; 2006 Jan 04; 316(1):364-70. PubMed ID: 16249369 [Abstract] [Full Text] [Related]
11. Cellular expression of V1a vasopressin receptor mRNA in the female rat preoptic area: effects of oestrogen. Kalamatianos T, Kalló I, Goubillon ML, Coen CW. J Neuroendocrinol; 2004 Jun 04; 16(6):525-33. PubMed ID: 15189327 [Abstract] [Full Text] [Related]
12. Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance. Nakamura K, Aoyagi T, Hiroyama M, Kusakawa S, Mizutani R, Sanbe A, Yamauchi J, Kamohara M, Momose K, Tanoue A. Eur J Pharmacol; 2009 Jun 24; 613(1-3):182-8. PubMed ID: 19375419 [Abstract] [Full Text] [Related]
13. Vasopressin receptor expression in the placenta. Koukoulas I, Risvanis J, Douglas-Denton R, Burrell LM, Moritz KM, Wintour EM. Biol Reprod; 2003 Aug 24; 69(2):679-86. PubMed ID: 12724283 [Abstract] [Full Text] [Related]
14. Evidence for the existence of vasopressin V2 receptor mRNA in rat hippocampus. Hirasawa A, Nakayama Y, Ishiharada N, Honda K, Saito R, Tsujimoto G, Takano Y, Kamiya H. Biochem Biophys Res Commun; 1994 Dec 30; 205(3):1702-6. PubMed ID: 7811254 [Abstract] [Full Text] [Related]
15. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice. Loffler M, Bilban M, Reimers M, Waldhäusl W, Stulnig TM. J Pharmacol Exp Ther; 2006 Feb 30; 316(2):797-804. PubMed ID: 16260581 [Abstract] [Full Text] [Related]
16. Impaired arginine-vasopressin-induced aldosterone release from adrenal gland cells in mice lacking the vasopressin V1A receptor. Birumachi J, Hiroyama M, Fujiwara Y, Aoyagi T, Sanbe A, Tanoue A. Eur J Pharmacol; 2007 Jul 02; 566(1-3):226-30. PubMed ID: 17449028 [Abstract] [Full Text] [Related]
17. Messenger RNA expressions of vasopressin system and aquaporin-2 in adriamycin-induced nephrotic rats and effects of astragalus membranaceus. Ma J, Fan S, Chen J, Gu Y, Lin S. Chin Med J (Engl); 1999 Dec 02; 112(12):1068-72. PubMed ID: 11721440 [Abstract] [Full Text] [Related]
18. Angiotensin II increases adipose angiotensinogen expression. Lu H, Boustany-Kari CM, Daugherty A, Cassis LA. Am J Physiol Endocrinol Metab; 2007 May 02; 292(5):E1280-7. PubMed ID: 17213477 [Abstract] [Full Text] [Related]
19. Glucose catabolic gene mRNA levels in skeletal muscle exhibit non-coordinate expression in hyperglycemic mice. Kato M, Suwa A, Shimokawa T. Horm Metab Res; 2004 Aug 02; 36(8):513-8. PubMed ID: 15326559 [Abstract] [Full Text] [Related]
20. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach. Oshikawa S, Tanoue A, Koshimizu TA, Kitagawa Y, Tsujimoto G. Mol Pharmacol; 2004 Mar 02; 65(3):623-9. PubMed ID: 14978240 [Abstract] [Full Text] [Related] Page: [Next] [New Search]